Screening de cancer colorrectal

Revista Clinica Espanola

Volumn 200, Issue 3, 2000, Pages 143-150

  Caicoya, M ^a  

^a HOSPITAL MONTE NARANCO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COLORECTAL TUMOR; COST BENEFIT ANALYSIS; ECONOMICS; HUMAN; INCIDENCE; MASS SCREENING; METHODOLOGY; MORTALITY; REVIEW; RISK FACTOR; SPAIN; STATISTICS; UNITED STATES;

COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; HUMANS; INCIDENCE; MASS SCREENING; MORTALITY; RISK FACTORS; SPAIN; UNITED STATES;

EID: 3042896349     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2565(00)70587-X     Document Type: Review

References (65)

1. American Cancer Society. Cancer information database. Colorectal cancer. American Cancer Society, 1998.
2. Schottenfeld D, Winawer SJ. Cancers of the large intestine. En: Schottenfeld D, Fraumeni JH, eds. Cancer epidemiology and prevention. New York: Oxford University Press, 1996; 813-840.
3. Anónimo. European Cancer Prevention News. European Cancer Prevention Organisation, 1997; 2-4.
4. Giovannucci E, Stampfer MJ, Colditz GA, et al. Multivitamin use, folate and colon cancer in women in the nurses' health study. Ann Int Med 1998; 129; 517-524.
5. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 328:1.365-1.371.
6. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348:1.467-1.471.
7. Hardcastle JD, Chamberlein JO, Robinson MHE, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348:1.472-1.477.
8. Winawer SJ, Fletcher RH, Miller L, Godle F, Stolar MH, Murlow CD. Colorectal cancer screening, clinical guidelines and rationale. Gastroenterology 1997; 112:594-642.
9. Prevention and detection guidelines. Updated guidelines for colorectal cancer detection. Guidelines for the cancer related checkup. American Cancer Society, 1997.
10. Colorectal cancer screening: recommendations of the US Preventive Task Force. Gastroenterology 1996; 111:1.381-1.384.
11. Early DS, Marshall JB. Is routine screening for colorectal cancer justificable. These gastroenterologists says yes. Postgrad Med 1997, 50-56.
12. Screening for colorectal cancer. NCI. PDQ®. Screening and Prevention Health Profesionals. Last updated 6/99.
13. Agency for Health Care Policy and Research. Colorectal cancer screening. Technical Review 1. AHPRC Publication No 98-0033 Rockville, MD. Agency for Health Care Policy and Research, 1998.
14. Australian Health Technology Advisory Committee. Colorectal Cancer Screening. Commonwealth Department of Health and Family Service. Camberra ACT, 1997.
15. Koretz DA. Is routine screening for colorectal cancer justifiable. This gastroenterologist says no. Postgrad Med 1997; 53-62.
16. Ahlquist DA. Fecal occult blood testing for colorectal cancer. Can we afford to do this. Gastroenterol Clin North Am 1997; 26:41-55.
17. Miller AB. Fundamental issues in screening for cancer. En: Schottenfeld D, Fraumeni JH, eds. Cancer epidemiology and prevention. Oxford, New York: Oxford University Press, 1996; 1.433-1.452.
18. Forrest P. Breast cancer screening. Report to the Health Ministers of England, Wales, Scotland & Northern Ireland. London: Her Majesty Stationary Office, 1986.
19. Mortalidad en Asturias, 1994. Oviedo: Servicio de Publicaciones del Principado de Asturias, 1998.
20. Incidencia de Cáncer en Asturias, 1991. Oviedo: Edición mimeografiada. Consejería de Sanidad del Principado de Asturias.
21. Correa P. Morphology and natural history of cancer precursors. En: Schottenfeld D, Fraumani JH, eds. Cancer epidemiology and prevention. New York: Oxford University Press, 1996.
22. Muller AD, Sonnembereg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case comrol study of 32.702 veterans. Ann Intern Med 1995; 123:904-910.
23. Winawer SJ, Zauber AG, Ho MN, et al for the National Polyp Study Workgroup. Prevention of colorectal cancer with colonoscopy polypectomy. N Engl J Med 1993; 329:197-202.
24. Spratt JS, Ackerma LV. Small primary adenocarcinomas of the colon and rectum. JAMA 1962; 279:337-346.
25. Eide TJ. Risk of colorectal cancer in adenomatous-bearing individuals within a defined population. Int J Cancer 1985; 38:173-176.
26. O'Brien MJ, Winawer SJ, Zauber AG, Gottieb LS, Stemberg SS, Díaz B, Dickeerson GR. The national polyp study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 1990; 98:371-379.
27. Muto T, Bussey HJR, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36:2.251-2.270.
28. Olsen HW, Lawrence WA, Snook CW, Mutch WM. Review of recurrent polyps and cancer in 500 patients with initial colonoscopy for polyps. Dis Colon and Rectum 1988; 31:222-227.
29. Williams AR, Balasooriya BAW, Day DW. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut 1982; 123:835-842.
30. Figiel LS, Figiel SJ, Wietersen FK. Roentgenologic observations of growth rates of colonic polyps and carcinoma. Acta Radiol Diag 1985; 3:417-428.
31. Koretz RL. Malignant polyps are they wolves in sheep clothing. Ann Intern Med 1993; 1.118:63-67.
32. Bond JH. Polyp guideline: diagnosis, treatment and surveillance for patients with nonfamilial colorectal polyps. The practice parameters committee of American College of Gastroenterology. Ann Intern Med 1993; 119:836-843.
33. Eddy D. Screening for colorectal cancer. Ann Intern Med 1990; 113:373-383.
34. SEER Cancer Statistics Review 1973-1994. National Cancer Institute.
35. Lang CA, Ransohoff DF. Fecal occult blood screening for colorectal cancer: is mortality reduced by chance selection for screening colonoscopy? JAMA 1994; 271:1.011-1.013.
36. Mandel JS, Church TR, Ederer F. Screening for colorectal cancer (letter). N Engl J Med 1993; 329:1.353-1.354.
37. Miller AB. Screening for breast cancer: a review. Eur J Cancer Clin Oncol 1988; 24:49-53.
38. Young GP, St. Jonn JB. Selecting an occult blood test for use as a screening tool for large bowel cancer. Front Gastrointest Res 1991; 18:135-156.
39. Ahlquist DA, Wieand HS, Moertel CD, et al. Accuracy of fecal occult blood screening for colorectal neoplasia. JAMA 1993;269:1.262-1.267.
40. John St John DJB, Young GP, McHutchinson JG, Deacon MC, Alexeyeff MA. Comparison of the specifity and sensitivity of hemoccult and hemoquant in screening for colorectal neoplasia. Annals Intern Med 1992; 117:376-382.
41. Walker A, Whynes DK. Filtering strategies in mass population screening for colorectal cancer. Med Decis Making 1992; 12:2-7.
42. Screening for colorectal cancer. Report of the US Preventive Task Force. Guide to clinical preventive services. Baltimore: Williams and Wilkins, 1989.
43. Rex DK, Rahman EY, Haseman JH, Lemmel GT, Kaster S, Buckley JS. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology 1997; 112:17-23.
44. Wayte J. What is a gold standard for colon polyps? Gastroenterology 1997; 112:306-308.
45. Winawer SJ. Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993; 329:1.977-1 981.
46. Ferrucci, Glick SN. Colonoscopy versus barium enema: a reappraisal of the facts and issues. Gastroenterology 1997; 113:1.048.
47. Ferrucci JT. Coloroscopy and barium enema: radiologist's response Gastroenterology 1997; 112:292-297.
48. Hixson LJ, Fernerly MB, Sampliner RE, Mc Gee D, Garewal H. Prospective study of the frequency and size distribution of polyps missed by colonoscopy. J Nat Cancer Inst 1990; 82:1.769-1.772.
49. Selby JV, Friedman GD, Quesemberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality form colorectal cancer. N Engl J Med 1992; 326:653-657.
50. Newcomb PA, Norfleet RG, Storer BE, Surawicz T, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992; 84:1.572-1.575.
51. Muller AD, Sonnemberg A. Protection by endoscopy against death form colorectal cancer. A case control among veterans. Arch Intern Med 1995; 155:1.741-1.748.
52. Petravage J, Swedberg J. Patients response to sigmoidoscopy recommendation via mailed reminders. J Fam Practice 1988; 27:387-390.
53. Verne JECW, Aubrey R, Talbot I, Northover JMA. Population based randomised study of uptake and yield of screening by flexible sigmoidoscopy compared by faecal occult blood testing. Br Med J 1998; 317:182-185.
54. Blalock SJ, McEvoy De Vellis B, Sandler R. Participation in fecal occult blood screening: a critical review. Prev Med 1987; 16:9-18.
55. Arveaux P, Durand G, Milan C, et al. Views of a general population on mass screening for colorectal cancer: the Burgandy Study. Prev Med 1992; 21:574-581.
56. Hoogerwerf PE, Hislop G, Morrison BJ, Burns SD, Siztu R. Health believe and compliance for fecal occult blood. Soc Sci Med 1990; 30:721-726.
57. Gilbertsen VA, Church TR, Grewe FJ, Mandel JS, McHugh RB, et al. The design of a study to assess occult-blood screening for colon cancer. J Chron Dis 1980; 33:107-114.
58. Lieberman DA. Cost-effectiveness model for colon cancer screening. Gastroenterology 1995; 109:1.781-1.790.
59. Wagner JL, Herdman RC, Sandeep W. Cost effectiveness of colorectal cancer screening. Ann Intern Med 1991; 115:807-809.
60. Caicoya M. Screening de cancer de próstata. Rev Clín Española 1994; 194:1.034-1.043.
61. Cribatge del cáncer de mam a Catalunya. Informe Tecnic. Barcelona: Agencia d Avaluació De Tecnología Médica. 1996.
62. Kattlove H, Liberati A, Keeler E, Brook RH. Benefits and costs of screening and treatment for early breast cancer. JAMA 1995; 273:142-148.
63. Situación del cáncer en Asturias. Descripción epidemiológica. Consejeria de Sanidad y Servicios Sociales. Dirección Regional de Salud Pública, 1994.
64. Estéve J, Kriker A, Parkin DM. Facts and figures of cancer in the European Community. Lyon: International Agency for Research of Cancer. 1993.
65. Cancer Incidence in Five Continents. Lyon: International Agency for Research of Cancer, 1992.